Table of Contents

Oncology

• Clinical

  • FEATURED ARTICLE OF THE MONTH

    • You have access

      Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using ⁸⁹Zr-DFO-MSTP2109A Anti-STEAP1 Antibody

      Jorge A. Carrasquillo, Bernard M. Fine, Neeta Pandit-Taskar, Steven M. Larson, Stephen E. Fleming, Josef J. Fox, Sarah M. Cheal, Joseph A. O’Donoghue, Shutian Ruan, Govind Ragupathi, Serge K. Lyashchenko, John L. Humm, Howard I. Scher, Mithat Gönen, Simon P. Williams, Daniel C. Danila and Michael J. Morris

      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1517-1523; DOI: https://doi.org/10.2967/jnumed.118.222844
  • You have access

    Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with ¹⁸F-FDG PET/CT

    Hossein Jadvar, Erik M. Velez, Bhushan Desai, Lingyun Ji, Patrick M. Colletti and David I. Quinn

    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1524-1530; DOI: https://doi.org/10.2967/jnumed.118.223263
  • You have access

    ¹⁸F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer

    Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster

    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  • You have access

    ¹⁸F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas

    Johannes Grueneisen, Benedikt Schaarschmidt, Aydin Demircioglu, Michal Chodyla, Ole Martin, Stefanie Bertram, Axel Wetter, Sebastian Bauer, Wolfgang Peter Fendler, Lars Podleska, Michael Forsting, Ken Herrmann and Lale Umutlu

    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1537-1542; DOI: https://doi.org/10.2967/jnumed.119.226761

  • INVITED PERSPECTIVE

    • You have access

      The Dark Side of Radiomics: On the Paramount Importance of Publishing Negative Results

      Irène Buvat and Fanny Orlhac

      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1543-1544; DOI: https://doi.org/10.2967/jnumed.119.235325
  • You have access

    Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma

    Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard and Marcel P.M. Stokkel

    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1545-1552; DOI: https://doi.org/10.2967/jnumed.119.228312
  • You have access

    Accuracy of ¹⁸F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

    Maria J. Valkema, Bo Jan Noordman, Bas P.L. Wijnhoven, Manon C.W. Spaander, Katharina Biermann, Sjoerd M. Lagarde, Roel J. Bennink, Wendy M.J. Schreurs, Mark J. Roef, Monique G.G. Hobbelink, Marcel J.R. Janssen, Laura H. Graven, J. Jan B. van Lanschot and Roelf Valkema

    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1553-1559; DOI: https://doi.org/10.2967/jnumed.118.224196
  • You have access

    ¹⁸F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer

    Antonio Avallone, Luigi Aloj, Biagio Pecori, Corradina Caracò, Alfonso De Stefano, Fabiana Tatangelo, Lucrezia Silvestro, Vincenza Granata, Francesco Bianco, Carmela Romano, Francesca Di Gennaro, Alfredo Budillon, Antonella Petrillo, Paolo Muto, Gerardo Botti, Paolo Delrio and Secondo Lastoria

    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1560-1568; DOI: https://doi.org/10.2967/jnumed.118.222604

• Basic

  • Open Access

    Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors

    Patrícia M.R. Pereira, Komal Mandleywala, Ashwin Ragupathi, Lukas M. Carter, Jeroen A.C.M. Goos, Yelena Y. Janjigian and Jason S. Lewis

    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1569-1578; DOI: https://doi.org/10.2967/jnumed.119.225813